CCL2 and breast cancer: In support of this evidence, it has been recently demonstrated that EVs positive for annexin-A6, released by cancer cells following chemotherapy, promote NF-κB-dependent endothelial cell activation, Ly6C+CCR2+ monocyte expansion, and MCP-1 induction to facilitate the establishment of breast cancer lung metastases [71].